Combine real-time decision support with workflow analytics
Most respondents say they are likely to hire more employees now
Not just for prostate cancer and fibroids
Managed equipment service contract trend rolls on
Bringing point-of-care testing to remote regions
Toward better pre-biopsy imaging and less invasive care
Revised manual available free online
Mid-size hospitals expected to generate $99.8 million by 2020
Bowel and lung cancer patients may benefit as well
Tested on nearly 100 amputees over 10,000 hours of use
Neurosurgical planning with diffusion tensor imaging
Advancements happening with both exam types
Clinicians can manipulate holograms of anatomy
Benefits of MR continue to outweigh risks for most patients
Researchers say the solution may be increased hospital centralization
Hoping to add valuable transparency to the care continuum
Maine among states with highest rate of lung cancer in U.S.
Institute for Radioelements in Belgium will replace supply from Canada reactor
Siemens system allows for range of applications, will free up CT
Previous source was over 1,000 miles away
Conventional applicators can’t always reach tumor
Company eyes industry leadership in precision medicine
System is one-third the standard size and will be used for neurological research
A step back from requiring advanced certification
Early progress in the pursuit of lifesaving apps
More than two dozen states now have dense breast notification laws
New progress in the war against 'invisible' injuries
Offloading $3 billion segment could be in the cards: report
Founder of pMD talks about solutions to the lack of physician communication
Investigating the role of the cerebellum
Solia S ProMRI comes in three different lengths
Contracts will not be altered but some are worried about the bottom line
$91 million investment made
Only 14 percent believe it reduces lung-cancer related deaths
Shows promise in pilot study
Often no symptoms of cardiac issues in these patients
By 2019 that number is expected to rise to 23 percent
Total cost of dementia worldwide was $818 billion in 2015
70 percent of Americans don’t know what to do during an event
Axumin is commercially available in U.S.
Better results than Tc-99m-MDP bone scans
A new metric to measure interoperability could drive innovation
Over 2,000 patients participating in study in seven months
California center will combine research and commercial production
Actual patient outcomes not representative of staffers' culture perceptions
Yields almost 20 percent more5-year survival benefit
Advancements in image-guided therapies are needed
250,000 men per year may avoid unnecessary biopsies
Sizing up tomosynthesis and MR as breast imaging solutions
Might be part of the early pathology of the condition